U.S.-Australia Rx “Transparency” Deal Applies To Medicare Part B
Medicare Part B drug reimbursement decisions will be subject to the transparency provisions of the U.S.-Australia Free Trade Agreement, the U.S. Trade Representative says
Medicare Part B drug reimbursement decisions will be subject to the transparency provisions of the U.S.-Australia Free Trade Agreement, the U.S. Trade Representative says